All measures listed on this page have been updated for the 2019 reporting year. Scoring note: The quality category contributes 45 percent to your overall 2019 Merit-Based Incentive Payment System score, down from 50 percent in 2018.
For more information on how to read a quality measure specification, see the Quality Measure Reading Guide.
Note: The following measures were removed for 2019 MIPS:
- Measure 18: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
- Measure 140: AMD: Counselling on Antioxidant Supplement
- Measure 224: Melanoma: Avoidance of Overutilization of Imaging Studies